Changing dynamics of bloodstream infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium in Germany, 2017–2023: a continued burden of disease approach

被引：0
|
作者：
Simon Brinkwirth [1 ]
Marcel Feig [2 ]
Ines Noll [3 ]
Tim Eckmanns [4 ]
Achim Dörre [1 ]
Sebastian Haller [1 ]
Niklas Willrich [1 ]
机构：
[1] Robert Koch Institute,Unit 37: Healthcare
[2] Robert Koch Institute,Associated Infections, Surveillance of Antibiotic Resistance and Consumption, Department of Infectious Disease Epidemiology
[3] European Centre for Disease Prevention and Control (ECDC),Department of Infectious Disease Epidemiology, Postgraduate Training for Applied Epidemiology (PAE)
[4] Robert Koch Institute,ECDC Fellowship Programme, Field Epidemiology Path (EPIET)
来源：
Antimicrobial Resistance & Infection Control | / 14卷 / 1期
关键词：
D O I：
10.1186/s13756-025-01522-9
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] In vitro susceptibility of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium to daptomycin and other antibiotics
    Z. Samra
    O. Ofir
    H. Shmuely
    European Journal of Clinical Microbiology & Infectious Diseases, 2007, 26 : 363 - 365
  • [2] In vitro susceptibility of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium to daptomycin and other antibiotics
    Samra, Z.
    Ofir, O.
    Shmuely, H.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (05) : 363 - 365
  • [3] Germany's Burden of Disease of Bloodstream Infections Due to Vancomycin-Resistant Enterococcus faecium between 2015-2020
    Brinkwirth, Simon
    Martins, Sofie
    Ayobami, Olaniyi
    Feig, Marcel
    Noll, Ines
    Zacher, Benedikt
    Eckmanns, Tim
    Werner, Guido
    Willrich, Niklas
    Haller, Sebastian
    MICROORGANISMS, 2022, 10 (11)
  • [4] In vitro antimicrobial activity of propolis against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium
    Kilic, A
    Baysallar, M
    Besirbellioglu, B
    Salih, B
    Sorkun, K
    Tanyuksel, M
    ANNALS OF MICROBIOLOGY, 2005, 55 (02) : 113 - 117
  • [5] Antibiotic and biocide resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus
    Suller, MTE
    Russell, AD
    JOURNAL OF HOSPITAL INFECTION, 1999, 43 (04) : 281 - 291
  • [6] Ultrastructural Effects of Oritavancin on Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus
    Belley, Adam
    Harris, Robert
    Beveridge, Terry
    Parr, Tom, Jr.
    Moeck, Gregory
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) : 800 - 804
  • [7] Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a rural state
    Polgreen, Philip M.
    Beekmann, Susan E.
    Chen, Yi Yi
    Doern, V.
    Pfaller, Michael A.
    Brueggemann, Angela B.
    Herwaldt, Loreen A.
    Diekema, Daniel J.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (03): : 252 - 256
  • [8] Vancomycin-resistant enterococcus (VRE) vs Methicillin-resistant Staphylococcus Aureus (MRSA)
    Ashwin, K. S.
    Muralidharan, N. P.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 33 : S166 - S167
  • [9] Evaluation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus
    Bardossy, Ana Cecilia
    Alsafadi, Muhammad Yasser
    Starr, Patricia
    Chami, Eman
    Pietsch, Jennifer
    Moreno, Daniela
    Johnson, Laura
    Alangaden, George
    Zervos, Marcus
    Reyes, Katherine
    AMERICAN JOURNAL OF INFECTION CONTROL, 2017, 45 (12) : 1369 - 1371
  • [10] Control of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in hospitalized children
    Fisher, MC
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (09) : 825 - 826
12345